Navigation Links
Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
Date:5/17/2013

SAN DIEGO, May 17, 2013 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the UBS Global Healthcare Conference in New York. The presentation is scheduled for Wednesday, May 22nd at 11 a.m. Eastern Time. To listen to the live webcast or a replay of the presentation, please visit the Investor Relations section of the Company's Web site at www.orexigen.com. A replay will be available for 14 days after the event.

About Orexigen® Therapeutics
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave®, which has completed Phase 3 clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment (SPA) for the Light Study, the Contrave cardiovascular outcomes trial. The Company's other product candidate, Empatic™, has completed Phase 2 clinical trials. Further information about the Company can be found at www.orexigen.com.Orexigen Contact:

Media Contact:  McDavid Stilwell

Denise PowellVP, Corporate Communications and Business Development

BrewLife(858) 875-8629

(510) 703-9491


'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
2. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
3. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
4. Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
5. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
6. Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012
7. Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences
8. Orexigen Therapeutics announces continued rapid enrollment into the Light Study; enrollment now expected to close by year end 2012
9. Orexigen Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2012
10. Orexigen Therapeutics To Host Analyst Day Event on December 18, 2012
11. Orexigen Therapeutics to Present at Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2020)... ... August 27, 2020 , ... Trella Health, the leading source ... of cloud CRM, marketing automation, and contact center solutions for senior living communities ... of Trella’s performance intelligence data and insights into Enquire’s CRM solution to serve ...
(Date:8/27/2020)... ... 27, 2020 , ... The GHT Companies , a leading developer and ... Feeding San Diego with a press conference at its manufacturing facility in Vista. ... of $5,000.00+ representing an overall donation result exceeding $30,000 to Feeding San Diego, Who: ...
(Date:8/26/2020)... , ... August 26, 2020 , ... AseptiScope, a privately ... Control Company of the Year by MedTech Outlook. , “AseptiScope is pleased ... the first time, clinicians who wear gloves on their hands, goggles on their eyes, ...
Breaking Medicine Technology:
(Date:9/3/2020)... ... September 03, 2020 , ... The growing adoption ... of Fall 2020 Virtual Conference, a two-day virtual event for radiology professionals that ... Beyond" is the follow-up to AuntMinnie.com's successful virtual event in spring 2020, in ...
(Date:9/1/2020)... ... September 01, 2020 , ... Board ... in Glendale. While the office will be the first to bear her name, ... buttock augmentation (Brazilian butt lift), as well as rhinoplasty, facial rejuvenation, and many ...
(Date:8/31/2020)... ... 2020 , ... Cardiothoracic surgeons at Allegheny General Hospital (AGH), ... University (CMU) to develop a new heart monitoring device designed to serve as ... The AGH/CMU team was recently awarded a “Trailblazer” grant from the National Institutes ...
(Date:8/31/2020)... ... August 31, 2020 , ... Genesis Chiropractic Software ... today the launch of its integrated, HIPAA compliant, telehealth solution, available to US-based ... in under 90 seconds. , According to the U.S. Department of Health ...
(Date:8/31/2020)... ... August 31, 2020 , ... In an effort to give back to the ... percent of each hotel room booked with a special new rate code to benefit ... (RMHC-CNI) , effective immediately. Donations will be applied to any room type, any ...
Breaking Medicine News(10 mins):